OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Alpha-peptide receptor radionuclide therapy using actinium-225 labeled somatostatin receptor agonists and antagonists
Mengqi Shi, Vivianne Jakobsson, Lukas Greifenstein, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 36
Mengqi Shi, Vivianne Jakobsson, Lukas Greifenstein, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 36
Showing 1-25 of 36 citing articles:
Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation
Shivang Dhoundiyal, Shriyansh Srivastava, Sachin Kumar, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 48
Shivang Dhoundiyal, Shriyansh Srivastava, Sachin Kumar, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 48
Carrier systems of radiopharmaceuticals and the application in cancer therapy
Taotao Zhang, Huiwen Lei, Xiaohua Chen, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 19
Taotao Zhang, Huiwen Lei, Xiaohua Chen, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 19
Implementing Ac-225 labelled radiopharmaceuticals: practical considerations and (pre-)clinical perspectives
Eline L. Hooijman, Valery Radchenko, Sui Wai Ling, et al.
EJNMMI Radiopharmacy and Chemistry (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Eline L. Hooijman, Valery Radchenko, Sui Wai Ling, et al.
EJNMMI Radiopharmacy and Chemistry (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Towards Effective Targeted Alpha Therapy for Neuroendocrine Tumours: A Review
Paul Gape, Michael K. Schultz, Graeme J. Stasiuk, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 334-334
Open Access | Times Cited: 14
Paul Gape, Michael K. Schultz, Graeme J. Stasiuk, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 334-334
Open Access | Times Cited: 14
Peptide Binder to Glypican-3 as a Theranostic Agent for Hepatocellular Carcinoma
Fanching Lin, Renee Clift, Takeru Ehara, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. 4, pp. 586-592
Closed Access | Times Cited: 13
Fanching Lin, Renee Clift, Takeru Ehara, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. 4, pp. 586-592
Closed Access | Times Cited: 13
Recent advances and impending challenges for the radiopharmaceutical sciences in oncology
Suzanne E. Lapi, Peter J. H. Scott, Andrew M. Scott, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 6, pp. e236-e249
Closed Access | Times Cited: 13
Suzanne E. Lapi, Peter J. H. Scott, Andrew M. Scott, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 6, pp. e236-e249
Closed Access | Times Cited: 13
A Radioluminescent Metal–Organic Framework for Monitoring 225Ac in Vivo
Yugang Zhang, Feize Li, Zhencun Cui, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 27, pp. 14679-14685
Closed Access | Times Cited: 20
Yugang Zhang, Feize Li, Zhencun Cui, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 27, pp. 14679-14685
Closed Access | Times Cited: 20
225Ac-Labeled Somatostatin Analogs in the Management of Neuroendocrine Tumors: From Radiochemistry to Clinic
Léa Rubira, Emmanuel Deshayes, Lore Santoro, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1051-1051
Open Access | Times Cited: 17
Léa Rubira, Emmanuel Deshayes, Lore Santoro, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1051-1051
Open Access | Times Cited: 17
Recent advances in the development of 225Ac- and 211At-labeled radioligands for radiotheranostics
Masayuki Munekane, Takeshi Fuchigami, Kazuma Ogawa
Analytical Sciences (2024) Vol. 40, Iss. 5, pp. 803-826
Open Access | Times Cited: 6
Masayuki Munekane, Takeshi Fuchigami, Kazuma Ogawa
Analytical Sciences (2024) Vol. 40, Iss. 5, pp. 803-826
Open Access | Times Cited: 6
Radiopharmaceuticals as combinatorial partners for immune checkpoint inhibitors
Jean‐Pierre Pouget, Timothy A. Chan, Lorenzo Galluzzi, et al.
Trends in cancer (2023) Vol. 9, Iss. 11, pp. 968-981
Open Access | Times Cited: 11
Jean‐Pierre Pouget, Timothy A. Chan, Lorenzo Galluzzi, et al.
Trends in cancer (2023) Vol. 9, Iss. 11, pp. 968-981
Open Access | Times Cited: 11
RYZ101 (Ac-225 DOTATATE) Opportunity beyond Gastroenteropancreatic Neuroendocrine Tumors: Preclinical Efficacy in Small-Cell Lung Cancer
Guangzhou Han, Eunmi Hwang, Fanching Lin, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 12, pp. 1434-1443
Open Access | Times Cited: 11
Guangzhou Han, Eunmi Hwang, Fanching Lin, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 12, pp. 1434-1443
Open Access | Times Cited: 11
Precision radiation opens a new window on cancer therapy
Melanie Senior
Nature Biotechnology (2024) Vol. 42, Iss. 7, pp. 1003-1008
Open Access | Times Cited: 4
Melanie Senior
Nature Biotechnology (2024) Vol. 42, Iss. 7, pp. 1003-1008
Open Access | Times Cited: 4
Ac-225 radiochemistry through the lens of [225Ac]Ac-DOTA-TATE
Eline L. Hooijman, J. R. de Jong, Carolline M. Ntihabose, et al.
EJNMMI Radiopharmacy and Chemistry (2025) Vol. 10, Iss. 1
Open Access
Eline L. Hooijman, J. R. de Jong, Carolline M. Ntihabose, et al.
EJNMMI Radiopharmacy and Chemistry (2025) Vol. 10, Iss. 1
Open Access
TANDEM Peptide Receptor Radionuclide Therapy Using [225Ac]Ac-/[177Lu]Lu-DOTA-LM3 in a Patient With Parotid Gland Metastasis From Pancreatic Neuroendocrine Neoplasm
Elisabetta Perrone, Kriti Ghai, Aleksandr Eismant, et al.
Clinical Nuclear Medicine (2025)
Closed Access
Elisabetta Perrone, Kriti Ghai, Aleksandr Eismant, et al.
Clinical Nuclear Medicine (2025)
Closed Access
Advances with radiopharmaceutical therapy in cancer
Nicolas Lepareur
Elsevier eBooks (2025)
Closed Access
Nicolas Lepareur
Elsevier eBooks (2025)
Closed Access
Targeted radioligand therapy: physics and biology, internal dosimetry and other practical aspects during 177Lu/225Ac treatment in neuroendocrine tumors and metastatic prostate cancer
Habibollah Dadgar, Ali Pashazadeh, Nasim Norouzbeigi, et al.
Theranostics (2025) Vol. 15, Iss. 10, pp. 4368-4397
Open Access
Habibollah Dadgar, Ali Pashazadeh, Nasim Norouzbeigi, et al.
Theranostics (2025) Vol. 15, Iss. 10, pp. 4368-4397
Open Access
Clinical application of targeted α-emitter therapy in gastroenteropancreatic neuroendocrine neoplasms
Naoyuki Yamaguchi, Jingjing Wei, Hajime Isomoto
Journal of Gastroenterology (2025)
Open Access
Naoyuki Yamaguchi, Jingjing Wei, Hajime Isomoto
Journal of Gastroenterology (2025)
Open Access
Molecular radiotherapy for adult type metastatic neuroendocrine tumours in children
Connie Peet, Caroline Elmaraghi, Tarek Abdel‐Aziz, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Open Access
Connie Peet, Caroline Elmaraghi, Tarek Abdel‐Aziz, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Open Access
Impressive Response to TANDEM Peptide Receptor Radionuclide Therapy with 177Lu/225AcDOTA-LM3 Somatostatin Receptor Antagonist in a Patient with Therapy-Refractory, Rapidly Progressive Neuroendocrine Neoplasm of the Pancreas
Elisabetta Perrone, Kriti Ghai, Aleksandr Eismant, et al.
Diagnostics (2024) Vol. 14, Iss. 9, pp. 907-907
Open Access | Times Cited: 3
Elisabetta Perrone, Kriti Ghai, Aleksandr Eismant, et al.
Diagnostics (2024) Vol. 14, Iss. 9, pp. 907-907
Open Access | Times Cited: 3
Development of [225Ac]Ac‑LNC1011 for targeted alpha-radionuclide therapy of prostate cancer
Xuejun Wen, Tianzhi Zhao, Hongzhang Yang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
Xuejun Wen, Tianzhi Zhao, Hongzhang Yang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
Intra-Arterial Delivery of Radiopharmaceuticals in Oncology: Current Trends and the Future of Alpha-Particle Therapeutics
Nathan Kauffman, James Morrison, Kevin D. O’Brien, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1138-1138
Open Access | Times Cited: 8
Nathan Kauffman, James Morrison, Kevin D. O’Brien, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1138-1138
Open Access | Times Cited: 8
Effective therapy with Bismuth-212 labeled macroaggregated albumin in orthotopic mouse breast tumor models
Nathan Kauffman, Satyendra Kumar Singh, James Morrison, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 7
Nathan Kauffman, Satyendra Kumar Singh, James Morrison, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 7
225Ac/213Bi radionuclide generators for the separation of 213Bi towards clinical demands
Hongshan Zhu, S. Heinitz, Koen Binnemans, et al.
Inorganic Chemistry Frontiers (2024) Vol. 11, Iss. 15, pp. 4499-4527
Open Access | Times Cited: 2
Hongshan Zhu, S. Heinitz, Koen Binnemans, et al.
Inorganic Chemistry Frontiers (2024) Vol. 11, Iss. 15, pp. 4499-4527
Open Access | Times Cited: 2
Radiolabeling and Preclinical Evaluation of Therapeutic Efficacy of225Ac-ch806 in Glioblastoma and Colorectal Cancer Xenograft Models
Christian Wichmann, Katherine A. Morgan, Zhipeng Cao, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. 9, pp. 1456-1462
Closed Access | Times Cited: 2
Christian Wichmann, Katherine A. Morgan, Zhipeng Cao, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. 9, pp. 1456-1462
Closed Access | Times Cited: 2
Preclinical Evaluation of226Ac as a Theranostic Agent: Imaging, Dosimetry, and Therapy
Helena Koniar, Luke Wharton, Aidan Ingham, et al.
Journal of Nuclear Medicine (2024), pp. jnumed.124.267999-jnumed.124.267999
Closed Access | Times Cited: 2
Helena Koniar, Luke Wharton, Aidan Ingham, et al.
Journal of Nuclear Medicine (2024), pp. jnumed.124.267999-jnumed.124.267999
Closed Access | Times Cited: 2
